Zydus Completes Major Stake Acquisition in Amplitude Surgical

Zydus Lifesciences Limited has completed the acquisition of an 85.6% stake in Amplitude Surgical. The agreement, finalized on July 29, 2025, followed initial arrangements with PAI and two minority shareholders signed in March. The acquisition was secured at €6.25 per share, totaling €256.8 million. Following this acquisition, Zydus will initiate a mandatory tender offer for the remaining shares.

Olivier Jallabert continues as CEO of Amplitude Surgical. The company has ended its liquidity contract since July 28, 2025. The tender offer, conditional on French Financial Market Authority approval, may commence in September 2025. This move aims to surpass 90% ownership, potentially leading to a squeeze-out of remaining shares.